Medizone International is a research and development stage company engaged in the development of an ozone-based treatment for diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), hepatitis and herpes; and in the development of its patented technology for the decontamination of blood, blood products and veterinary serum products. It is currently pursuing new patents for the external application of its Medizone technology for medical purposes. Triatomic Oxygen, known as O3 or ozone, is the first layer of atmospheric protection interfacing the vastness of the cosmos with Earth. Ozone's healing properties have been known for many years and the use of medical ozone pre-dates WW I. The drug Medizone, or ozone, is a precisely manufactured and dosed combination of 02 and 03. Conceptually unique, at ambient temperature, 03 has a half life of one hour and in approximately 18 hours reverts to 02 in its entirety.
Partial Data by Infogroup (c) 2024. All rights reserved.